Milind Thatte, Managing Director, Procter & Gamble Health Limited and Vice President, Consumer Health-India Sub-continent speaks to Ashwini Prakash, Managing Partner and Board Director, Singapore and India, Stanton Chase, about the challenges posed during the pandemic, growth opportunities and lessons learnt
Did the pandemic pose a challenge OR a growth opportunity for pharma & healthcare industry? Your views
All through the pandemic, our challenge and primary focus has been and continues to be to protect the health and ensure the safety of our employees and partners; maintain the uninterrupted supply of our vitamins, minerals, supplements and medicinal products for patients and consumers; and support communities through relief efforts.
The onset of the pandemic initially posed two challenges for the industry. One was on the supply chain front where there was impact on multiple fronts: raw material, packaging material, and several other critical components. The other was on the distribution of finished goods and reaching them to the pharmacies, to ensure they reached our consumers and patients on time. These were the challenges for the first two months, until till the whole industry and government came together in a collaborative effort to address them. For e. g – the transporters were granted permission overnight to enter factories, although we were under a national lockdown.
Subsequently we faced another challenge in how to manage our salesf